CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong · Delayed Price · Currency is HKD 12.65
-0.78 (-5.81%)
Sep 10, 2026, 1:44 PM HKT
HKG:2171 Market Cap
HKG:2171 has a market cap or net worth of 7.55 billion as of September 9, 2026. Its market cap has decreased by -40.87% in one year.
Market Cap
7.55B
Enterprise Value
6.01B
Revenue
157.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.65
ChartMarket Cap Chart
Since June 18, 2021, HKG:2171's market cap has decreased from 17.02B to 7.55B, a decrease of -55.63%. That is a compound annual growth rate of -14.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 7.55B | -8.51% |
| Dec 31, 2025 | 8.25B | 63.11% |
| Dec 31, 2024 | 5.06B | 35.24% |
| Dec 29, 2023 | 3.74B | -56.36% |
| Dec 30, 2022 | 8.57B | -45.06% |
| Dec 31, 2021 | 15.61B | -8.30% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 10.66B |
| GenFleet Therapeutics (Shanghai) | 10.19B |
| CStone Pharmaceuticals | 9.87B |
| LongBio Pharma (Suzhou) | 9.50B |
| Shaanxi Micot Pharmaceutical Technology | 9.47B |
| TenNor Therapeutics (Suzhou) | 8.79B |
| Alphamab Oncology | 8.49B |
| Lepu Biopharma | 7.85B |